Skip to content
Home/Companies/HealthTech/Amelia

Amelia

HealthTech·Spain·Exited 2023·Held 4yr
Entry
2019
Hold
4yr
Exit
2023

Who owns Amelia?

Amelia was owned by Asabys Partners through Sabadell Asabys Health Innovation Investments (2019 vintage) from 2019 to 2023, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-09

Asabys Partners
Investor
Asabys Partners
Sabadell Asabys Health Innovation Investments · 2019 · Life Sciences VC

Key facts

HQSpain
SectorHealthTech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2023

More from Sabadell Asabys Health Innovation Investments

Other portfolio companies in the same fund.

Accure Therapeutics
Active
BiotechSpain· 2025
Qida
Active
HealthTechSpain· 2025
XRHealth
XRHealth
Active
HealthTechUnited States· 2023
Splice Bio
Splice Bio
Active
BiotechSpain· 2022
Agomab
Agomab
Exited 2026
BiotechBelgium· 2021
INBRAIN Neuroelectronics
INBRAIN Neuroelectronics
Active
MedTechSpain· 2020

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

52North Health
52North Health
Active
Future Planet CapitalUK
Akrivia Health
Akrivia Health
Active
Future Planet CapitalUK
Paladin
Paladin
Active
Ring CapitalFrance
Access Infinity
Active
CBPE CapitalUK· 2026
Auryx
Active
VentoUnited Kingdom· 2026
Axomove
Axomove
Active
INCO VENTURESFrance· 2026
Track Amelia

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Amelia.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue